These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis. Varga EM, Jacobson MR, Masuyama K, Rak S, Till SJ, Darby Y, Hamid Q, Lund V, Scadding GK, Durham SR. Eur Respir J; 1999 Sep; 14(3):610-5. PubMed ID: 10543283 [Abstract] [Full Text] [Related]
5. Nasal lavage mediator profile and cellular composition of nasal brushing material during latex challenge tests. Raulf-Heimsoth M, Wirtz C, Papenfuss F, Baur X. Clin Exp Allergy; 2000 Jan; 30(1):110-21. PubMed ID: 10606938 [Abstract] [Full Text] [Related]
6. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis. Di Lorenzo G, Drago A, Esposito Pellitteri M, Candore G, Colombo A, Gervasi F, Pacor ML, Purello D'Ambrosio F, Caruso C. Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734 [Abstract] [Full Text] [Related]
7. Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis. Greiff L, Persson CG, Svensson C, Enander I, Andersson M. J Allergy Clin Immunol; 1995 Jul; 96(1):97-103. PubMed ID: 7542675 [Abstract] [Full Text] [Related]
8. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls. de Graaf-in t Veld C, Garrelds IM, Koenders S, Gerth van Wijk R. Clin Exp Allergy; 1996 Aug; 26(8):903-8. PubMed ID: 8877155 [Abstract] [Full Text] [Related]
10. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis. Wang JH, Devalia JL, Duddle JM, Hamilton SA, Davies RJ. J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684 [Abstract] [Full Text] [Related]
12. Antiallergic actions of high topical doses of terbutaline in human nasal airways. Svensson C, Greiff L, Andersson M, Alkner U, Grönneberg R, Persson CG. Allergy; 1995 Nov; 50(11):884-90. PubMed ID: 8748720 [Abstract] [Full Text] [Related]
13. Mast cell TNF mRNA expression in nasal mucosa demonstrated by in situ hybridization: a comparison of mast cell detection methods. Anderson WH, Davidson TM, Broide DH. J Immunol Methods; 1996 Feb 05; 189(2):145-55. PubMed ID: 8613667 [Abstract] [Full Text] [Related]
14. Pavlovian conditioning of nasal tryptase release in human subjects with allergic rhinitis. Gauci M, Husband AJ, Saxarra H, King MG. Physiol Behav; 1994 May 05; 55(5):823-5. PubMed ID: 8022900 [Abstract] [Full Text] [Related]
15. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis. de Graaf-in 't Veld T, Garrelds IM, van Toorenenbergen AW, Mulder PG, Gerth van Wijk R, Boegheim JP. Ann Allergy Asthma Immunol; 1995 Sep 05; 75(3):261-6. PubMed ID: 7552929 [Abstract] [Full Text] [Related]
16. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. Knani J, Campbell A, Enander I, Peterson CG, Michel FB, Bousquet J. J Allergy Clin Immunol; 1992 Dec 05; 90(6 Pt 1):880-9. PubMed ID: 1334102 [Abstract] [Full Text] [Related]
17. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine. Jacobi HH, Skov PS, Poulsen LK, Malling HJ, Mygind N. J Allergy Clin Immunol; 1999 May 05; 103(5 Pt 1):768-72. PubMed ID: 10329808 [Abstract] [Full Text] [Related]